Clinical Pharmacogenomics: Opportunities and Challenges at Point of Care

    loading  Checking for direct PDF access through Ovid


One of the major barriers to implementing clinical pharmacogenomics has been the efficient integration of rapid turnaround-time genetic testing into routine clinical practice. To address this specific challenge, both point-of-care and preemptive pharmacogenomic testing programs, initially centered on cardiovascular pharmacogenomics, have recently been deployed. Early results indicate that these strategies are feasible and probably beneficial clinically; however, despite these exciting advances toward implementing clinical pharmacogenomics, challenges to widespread adoption remain.

Related Topics

    loading  Loading Related Articles